Poultry News
  • Production
    • Broiler Production
    • Ducks
    • Egg Production
    • Game
    • Hatching
    • Housing
    • Turkeys
  • Processing
  • Business & Politics
    • Business
    • Economics
    • EU & Politics
    • Marketing
    • People
    • Training & Education
  • Welfare
    • Environment
    • Food Safety
    • Vet & Medication
    • Welfare
  • Feed
  • Genetics
  • New Products
  • Magazines
    • July 2025
    • 2025 National Egg and Poultry Awards finalists supplement
    • June 2025
    • 2025 Innovation supplement
    • May 2025
    • April 2025
    • March 2025
    • 2025 Feed and Nutrition supplement
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • 2024 Building for the Future supplement
    • August 2024
    • 2024 Poultry Health supplement
    • July 2024
    • 2024 National Egg and Poultry Awards finalists supplement
    • June 2024
    • 2024 Innovation supplement
    • Pig & Poultry Fair 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • Processing Equipment Supplement – Nov 2023
    • October 2023
    • Building Supplement – Sept 2023
    • September 2023
  • Jobs
    • Browse Jobs
    • Post a Job
    • Manage Jobs
  • Events
    • National Egg and Poultry Awards
    • Poultry Fair
    • Webinars
Twitter LinkedIn
  • FREE Email Newsletters
  • About Us
  • Advertise
  • Subscribe
  • Contact Us
Twitter LinkedIn
Podcast
Poultry News
  • Production
    • Broiler Production
    • Ducks
    • Egg Production
    • Game
    • Hatching
    • Housing
    • Turkeys
  • Processing
  • Business & Politics
    • Business
    • Economics
    • EU & Politics
    • Marketing
    • People
    • Training & Education
  • Welfare
    • Environment
    • Food Safety
    • Vet & Medication
    • Welfare
  • Feed
  • Genetics
  • New Products
  • Magazines
    1. July 2025
    2. 2025 National Egg and Poultry Awards finalists supplement
    3. June 2025
    4. 2025 Innovation supplement
    5. May 2025
    6. April 2025
    7. March 2025
    8. 2025 Feed and Nutrition supplement
    9. February 2025
    10. January 2025
    11. December 2024
    12. November 2024
    13. October 2024
    14. September 2024
    15. 2024 Building for the Future supplement
    16. August 2024
    17. 2024 Poultry Health supplement
    18. July 2024
    19. 2024 National Egg and Poultry Awards finalists supplement
    20. June 2024
    21. 2024 Innovation supplement
    22. Pig & Poultry Fair 2024
    23. May 2024
    24. April 2024
    25. March 2024
    26. February 2024
    27. January 2024
    28. December 2023
    29. November 2023
    30. Processing Equipment Supplement – Nov 2023
    31. October 2023
    32. Building Supplement – Sept 2023
    33. September 2023
    Featured

    Poultry Business – July 2025 issue

    By Chloe RyanJuly 1, 2025
    Recent

    Poultry Business – July 2025 issue

    July 1, 2025

    Poultry Business – 2025 National Egg and Poultry Awards finalists supplement

    July 1, 2025

    Poultry Business – June 2025 issue

    June 9, 2025
  • Jobs
    • Browse Jobs
    • Post a Job
    • Manage Jobs
  • Events
    • National Egg and Poultry Awards
    • Poultry Fair
    • Webinars
Twitter LinkedIn
Poultry News
News

Influenza antibodies made by Pirbright reduce disease in chickens

Chloe RyanBy Chloe RyanApril 17, 20203 Mins Read
Facebook Twitter LinkedIn Email
Share
Facebook Twitter LinkedIn Email

Scientists at The Pirbright Institute have engineered synthetic antibody molecules that can be administered to poultry to reduce the symptoms of influenza, as well as decreasing the amount of influenza virus they shed into the environment. These results suggest that there is potential for their use as immunotherapy treatments to reduce the burden of influenza in poultry.
The team generated synthetic antibodies against the H9N2 strain of avian influenza, a type of influenza virus that poses great risks to the global poultry industry as well as to the health of other avian and mammalian species owing to its ability to readily mutate and adapt to new hosts.
The modified antibody segments, known as single chain variable fragment antibodies (scFvs), were shown to prevent the H9N2 virus from entering cells in laboratory tissue cultures. Further testing demonstrated that chickens immunised intranasally with scFvs produced lower levels of virus and presented decreased weight loss compared to those that had not received treatment.
The scFv antibodies work by binding to proteins on the outside of the influenza virus, called haemagglutinin (HA), that attach to receptors on host cells. This prevents the virus from entering the cell and replicating, offering rapid protection to infected birds.
Immunotherapy treatments such as synthetically made antibodies have become popular as they are able to be rapidly produced in large quantities in cultured cells, function in a similar way to natural antibody immune responses and provide immediate protection compared to vaccines.
To create the scFvs, the team immunised mice with an influenza vaccine, which triggered the production of mouse antibodies that could neutralise the H9N2 virus. The genetic code for two sections of the antibodies that bind to the HA protein was then sequenced. Using genetic engineering, they linked these two sections together to create one new smaller antibody molecule (the scFvs).
By generating these smaller molecules, the team could overcome issues presented by using whole antibodies such as lower production rates and increased likelihood of immune rejection by species other than chickens. The scFvs created in this study, published in Vaccines, have additional advantages including their ability to be mass produced in insect cells and the fact they could work against the virus in all hosts without adaption.
Professor Munir Iqbal, Head of the Avian Influenza Group at Pirbright, said: “These results are encouraging and demonstrate that scFvs could provide a quick and efficient way of reducing the clinical signs of influenza and its spread in infected flocks, reducing the risk of transmission from poultry to humans. The next step will be to establish the best method for administration, whether this be intranasally, as we have done in this study, or via aerosol or viral vector delivery systems. We anticipate that this type of immunotherapy could also be used to treat other viral diseases of poultry and humans by creating the appropriate synthetic antibodies for those diseases.”

Share. Facebook Twitter LinkedIn Email
Previous ArticleRed Tractor to introduce online audits via smartphone
Next Article High pathogenic AI confirmed in USA in first outbreak since 2017
Chloe Ryan

Editor of Poultry Business, Chloe has spent the past decade writing about the food industry from farming, through manufacturing, retail and foodservice. When not working, dog walking and reading biographies are her favourite hobbies.

Read Similar Stories

News

National Egg & Poultry Awards: Winners announced!

July 9, 20257 Mins Read
Feed & Nutrition

ABN kicks off major feed mill project

July 8, 20251 Min Read
Feed & Nutrition

Why probiotics deserve a place in turkey diets

July 7, 20253 Mins Read
Latest News

EFSA warns of bird migration and US imports pathways for AI into Europe

July 11, 2025

Comment: New catching rules are a disaster

July 10, 2025

Comment: Skills for what?

July 10, 2025
Sponsored Content

Navigating Sustainability in Egg Production: Practical Steps for Producers

June 1, 2025

Maintain stable and continuous coccidiosis control amidst stocking density reductions

November 1, 2024
© 2024 MA Agriculture Ltd, a Mark Allen Group company

Privacy Policy | Cookies Policy | Terms & Conditions

  • Farmers Weekly
  • AA Farmer
  • Farm Contractor
  • Pig World

Type above and press Enter to search. Press Esc to cancel.